I am responsible for designing and executing a global strategy to embed inclusive research principles — Access, Inclusion, and Representation (AIR) in priority countries in Latin America.

I support the Roche/Genentech Organization through the design and delivery of Quality Assurance strategies for Good Laboratory Practice (GLP), Good Clinical Practice (GCP), Good Pharmacovigilance Practice (GVP) and Computer Systems (CS).

I provide technical assistance in protocol design, research operationalization and disease surveillance. This supports ADEE 3002, a medical research cohort that began enrolling patients in 1987 and conducts several sponsored, investigator initiated and epidemiological studies in a population of People Living with HIV (PLHIV).

I was accountable for the delivery of the operational components of assigned clinical studies from Phase Ib-IV in line with the Asset and Therapeutic Area (TA)/Disease Area (DA) strategy, including timelines, budget and quality expectations, as well as timely and accurate data entry in our systems.

I Provided leadership through partnerships/collaboration with site leadership, SMEs, Process Owners, Regulatory Compliance and key stakeholders, to oversee execution of program management activities for compliance improvements.